Reducing asthma attacks in children using exhaled nitric oxide (RAACENO) as a biomarker to inform treatment strategy: a multicentre, parallel, randomised, controlled, phase 3 trial
Turner, S., Cotton, S., Wood, J., Bell, V., Raja, E. A., Scott, N., Morgan, H., Lawrie, L., Emele, D., Kennedy, C., Scotland, G., Fielding, S., MacLennan, G., Norrie, J., Forrest, M., Gaillard, E. A., de Jongste, J. C., Pijnenburg, M. W., Thomas, M., Price, D.
The Lancet. Respiratory medicine, vol. 10, no. 6, pp. 584-592
Reducción persistente de corticosteroides orales independientemente de la dosis basal, en pacientes con asma córtico-dependiente tratados con dupilumab: Estudio Liberty Asthma-Traverse
Domingo, C., Gurnell, M., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
Persistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study
Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
The 35th annual Eastern Allergy Conference, pp. S9
Quality Standard Position Statements for Health System Policy Changes in Diagnosis and Management of COPD: A Global Perspective
Bhutani, M., Price, D., Winders, T. A., Worth, H., Gruffydd-Jones, K., Tal-Singer, R., Correia de Sousa, J., Dransfield, M. T., Peché, R., Stolz, D., Hurst, J. R.
Treatment guided by fractional exhaled nitric oxide in addition to standard care in 6- to 15-year-olds with asthma: the RAACENO RCT
Turner, S., Cotton, S., Wood, J., Bell, V., Raja, E. A., Scott, N., Morgan, H., Lawrie, L., Emele, D., Kennedy, C., Scotland, G., Fielding, S., MacLennan, G., Norrie, J., Forrest, M., Gaillard, E. A., de Jongeste, J., Pijnenburg, M. W., Thomas, M., Price, D.
Factors associated with health status and exacerbations in COPD maintenance therapy with dry powder inhalers
W. H. Kocks, J., Wouters, H., Bosnic-Anticevich, S., van Cooten, J., Correia de Sousa, J., Cvetkovski, B., Dekhuijzen, R., Dijk, L., Dvortsin, E., Garcia Pardo, M., Gardev, A., Gawlik, R., van Geer - Postmus, I., van der Ham, I., Harbers, M., de la Hoz, A., Janse, Y., Kerkhof, M., Lavorini, F., Maricoto, T., Meijer, J., Metz, B., Price, D., Roman-Rodriguez, M., Schuttel, K., Stoker, N., Tsiligianni, I., Usmani, O., Leving, M. T.
npj Primary Care Respiratory Medicine, vol. 32, no. 1, 18
Evaluation of critical inhalation technique errors in patients with COPD on Dry Powder Inhaler maintenance therapy based on their association with health status: findings from the PIFotal study.
Kocks, J. W. H., Bosnic-Anticevich, S. Z., van Cooten, J., Correia de Sousa, J., Dekhuijzen, P. N. R., Dijk, L., Garcia Pardo, M., Gardev, A., Gawlik, R., van der Ham, I., Janse, Y., Lavorini, F., Maricoto, T., Meije, J., Metz, B., Price, D., Rodríguez, M. R., Schuttel, K., Stoker, N., Tsiligianni, I., Usmani, O., Voorham, J., Leving, M., Cvetkosvki, B.
Suboptimal peak inspiratory flow and inhalation technique errors are associated with higher COPD-relateD healthcare costs: results from the PIFotal COPD study
Leving, M., van Boven, J. F., Bosnic-Anticevich, S. Z., van Cooten, J., Correia de Sousa, J., Cvetkosvki, B., Dekhuijzen, P. N. R., Dijk, L., Garcia Pardo, M., Gardev, A., Gawlik, R., van der Ham, I., Hartgers-Gubbels, L., Janse, Y., Lavorini, F., Maricoto, T., Meijer, J., Metz, B., Price, D., Roman-Rodriguez, M., Schuttel, K., Stoker, N., Tsiligianni, I., Usmani, O., Kocks, J. W.
The burden of intermittent oral corticosteroid use in asthma
Heatley, H., Tran, T. N., Bourdin, A., Menzies-Gow, A., Jackson, D. J., Maslova, E., Chapaneri, J., Skinner, D., Carter, V., Shi Kai Chan, J., Ariti, C., Haughney, J., Price, D.
Adverse Outcomes Post-initiation of Systemic Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease: A Long-term Observational UK-based Study
Price, D., Bafadhel, M., Papi, A., Carter, V., Tse, G., Ariti, C., Zhou, J., Skinner, D., Xu, X., Müllerová, H., Emmanuel, B.
Impact of initiating biologics in patients with severe asthma and on long-term oral corticosteroids or rescue steroids (GLITTER)
Chen, W., Tran, T. N., Sadatsafavi, M., Wong, N. C. B., Bulathsinhala, L., Gil, E. G., FitzGerald, J. M., Murray, R. B., Price, D., ISAR GLITTER Working Group
Persistent Reductions in OCS Use in Patients with Severe, OCS-Dependent Asthma Treated with Dupilumab: LIBERTY ASTHMA TRAVERSE Study
Gurnell, M., Ribas, C. D., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
Predicting Pneumonia events in COPD patients using medical records
Price, D., Henley, W., Carter, V., Skinner, D., Alexander, L., Vella, R., Papi, A., Fabbri, L. M., Kerstjens, H. A., Roche, N., Singh, D., Vogelmeier, C. F., Şen, E., Delfini Cançado, J. E., Kots, M., Nudo, E., Barile, S., Georges, G.
Prevalence of comorbidities in adults with severe asthma: results from the International Severe Asthma Registry (ISAR)
Scelo, G., Porsbjerg, C. M., Carter, V., Ariti, C., Lyu, J., Eleangovan, N., Tran, T. N., Baker, P., Katial, R., Martin, N., Altraja, A., Rhee, C. K., FitzGerald, J. M., Hansen, S., Heaney, L. G., Hew, M., Siyue, M. K., Pfeffer, P. E., Puggioni, F., Tsai, M., von Bülow, A., Eileen, W., Price, D., ISAR PRISM Working Group
Prototype ORACLE Score Validation in NOVELTY: Predicted versus Observed Asthma Exacerbation Rates
Couillard, S., Peterson, S., Bengtsson, T., van den Berge, M., Price, D., Beasley, R., Sadatsafavi, M., Janson, C., Belton, L., Fagerås, M., Müllerová, H., Pavord, I. D.
Relationships Between Symptoms and Lung Function in Asthma and/or Chronic Obstructive Pulmonary Disease in the NOVELTY study
Papi, A., Hughes, R., Olmo, R. d., Agusti, A., Chipps, B. E., Make, B., Tomaszewski, E., Peres Da Costa, K., Srivastava, D., Vestbo, J., Janson, C., Burgel, P., Price, D.
Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma
Porsbjerg, C. M., Menzies-Gow, A., Tran, T. N., Murray, R. B., Unni, B., Ang, S. L. A., Alacqua, M., Al-Ahmad, M., Al-Lehebi, R., Altraja, A., Belevskiy, A. S., Björnsdóttir, U. S., Bourdin, A., Busby, J., Walter Canonica, G., Christoff, G., Cosio, B. G., Costello, R. W., FitzGerald, J. M., Fonseca, J. A., Hansen, S., Heaney, L. G., Heffler, E., Hew, M., Iwanaga, T., Jackson, D. J., Kocks, J. W. H., Kallieri, M., Bruce Ko, H., Siyue, M. K., Larenas-Linnemann, D., Lehtimäki, L. A., Loukides, S., Lugogo, N., Maspero, J. F., Papaioannou, A. I., Perez de Llano, L., Márcio Pitrez, P., Popov, T. A., Rasmussen, L. M., Rhee, C. K., Sadatsafavi, M., Schmidt, J., Siddiqui, S., Taillé, C., Taube, C., Torres-Duque, C. A., Ulrik, C., Upham, J. W., Eileen, W., Wechsler, M. E., Bulathsinhala, L., Carter, V., Chaudhry, I., Eleangovan, N., Hosseini, N., Rowlands, M., Price, D., van Boven, J. F.
The Journal of Allergy and Clinical Immunology: In Practice, vol. 10, no. 5
Variation in demographic and clinical characteristics of Patients with COPD receiving care in U.S. primary care: data from the Advancing the Patient EXperience (APEX) in COPD registry
Fox, C., Pace, W. D., Brandt, E., Chang, K., Edwards, C. L., Evans, A., Gaona, G., Han, M. K., Kaplan, A., Kent, R., Kocks, J. W., Kruszyk BEng, M., Le Lievre, C. E., Li Voti, T., Mahle, C., Make, B., Ratigan, A. R., Shaikh, A., Skolnik, N., Stanley, B., Yawn, B. P., Price, D.
Pragmatic and Observational Research, vol. 2022, no. 13, pp. 17-31
Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial. (BICS)
Cotton, S., Devereux, G., Abbas, H., Briggs, A. H., Campbell, K., Chaudhuri, R., Choudhury, G., Dawson, D., De Soyza, A., Fielding, S., Gompertz, S., Haughney, J., Lang, C. C., Lee, A., MacLennan, G., MacNee, W., McCormack, K., McMeekin, N., Mills, N. L., Morice, A., Norrie, J., Petrie, L., Price, D., Short, P., Vestbo, J., Walker, P., Wedzicha, J. A., Wilson, A., Lipworth, B. J.
Asthma exacerbation and steroid burden in Australian primary care
Price, D., Hancock, K. L., Bosnic-Anticevich, S., Blakey, J., Hew, M., Chung, L. P., Cvetkovski, B., Claxton, S., Del Fante, P., Denton, E., Doan, J., Ranasinghe, K., Morgan, L., Sharma, A., Smith, P. K., Feldman-Stewart, D., Thompson, P., Wiseman, R., Upham, J. W., Yan, K. Y., Carter, V., Dhillon, K., Heraud, F., Le, T., Vella, R., OPCA Improving Asthma outcomes in Australia Research Group
The Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science 2022, pp. 194
No difference in pneumonia risk in COPD patients initiating fixed dose combination (FDC) inhaler comprising extrafine beclometasone dipropionate versus long-acting bronchodilators
Price, D., Henley, W., Carter, V., Skinner, D., Vella, R., Papi, A., Fabbri, L. M., Kertsjens, H., Roche, N., Singh, D., Vogelmeier, C., Sen, E., Cancado, J., Nudo, E., Barile, S., Georges, G.
